Previous Close | 133.72 |
Open | 131.59 |
Bid | 132.48 x 1400 |
Ask | 132.41 x 800 |
Day's Range | 130.38 - 133.25 |
52 Week Range | 126.94 - 231.00 |
Volume | |
Avg. Volume | 306,055 |
Market Cap | 4.478B |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | 24.88 |
EPS (TTM) | 5.35 |
Earnings Date | Jul 25, 2022 - Jul 29, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 140.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for MEDP
Illumina (ILMN) is working on its goals to strengthen its foothold in the multi-billion gene sequencing market with some highly competitive products in its existing portfolio and pipeline.
Investors are optimistic about Haemonetics's (HAE) better-than-expected results and robust segmental performance.
The acquisition of EYSUVIS complements Alcon's (ALC) Systane family of eye drops offering, strengthening its treatment options for dry eye disease.